Hunter, Lawrence E
- University of Colorado · Pharmacology (NIH department code)
- University of Colorado (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
FY2022 NIH rank #11,022
- Sustained Excellence
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award categories
- Pharmacology
NIH Funding · FY2022
Linked Award Amount
$911.3K
Full award amounts, FY2022
Award Records
2
Records listing this PI
Award-Linked Rank
#11,022
By linked amount among FY2022 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2022 award records by amount
NIH award records listing Hunter, Lawrence E as a PI. Multi-PI records show the full award amount for context.
- $466.1Kaward amount
- 5R01LM013400-03R01Contact PIScientific Questions: A New Target for Biomedical NLPUniversity of Colorado · Pharmacology (NIH department code)$445.2Kaward amount
Award organization
Organizations that administered FY2022 awards listing Hunter, Lawrence E as a PI.
FY2022 award administered by University of Colorado (CO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardUniversity of Colorado
- 2006$500K Cumulative Funding
- 2006Entered Top 50% NationallyRanked #5384
- 2007$1M Cumulative Funding
- 2007$2M Cumulative Funding
- 2007Entered Top 25% NationallyRanked #3093
- 2009$5M Cumulative Funding
- 2009Entered Top 10% NationallyRanked #1827
- 2010$10M Cumulative Funding
- 2011R01 Grant Holder
- 2019$25M Cumulative Funding